|
HY-13030-1g
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-10mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-100mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-2mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-5mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-50mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-500mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-1mL
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-112789-10mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112789-100mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112789-25mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112789-5mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112789-50mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112789-1mL
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-15319A-10mg
|
MedChemexpress LLC
|
(�)-AMG 487 [CAS 947536-03-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-10mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-100mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-200mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-25mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-5mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-50mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-1mL
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-126037-1mg
|
MedChemexpress LLC
|
(�)-ML 209 [CAS 1334526-14-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
